Eagle Asset Management Inc Krystal Biotech, Inc. Transaction History
Eagle Asset Management Inc
- $16.7 Billion
- Q3 2024
A detailed history of Eagle Asset Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 63,602 shares of KRYS stock, worth $11.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
63,602
Previous 76,259
16.6%
Holding current value
$11.7 Million
Previous $14 Million
17.41%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$725 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$529 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$483 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$235 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$162 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.72B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...